Role of the Immune system in chronic pain (original) (raw)

• Numazaki, M. & Tominaga, M. Nociception and TRP Channels. Curr. Drug Targets CNS Neurol. Disord. 3, 479–485 (2004).
  Article CAS PubMed Google Scholar
• Lewin, G. R. & Moshourab, R. Mechanosensation and pain. J. Neurobiol. 61, 30–44 (2004).
  Article PubMed Google Scholar
• Cook, S. P., Vulchanova, L., Hargreaves, K. M., Elde, R. & McCleskey, E. W. Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 387, 505–508 (1997).
  Article CAS PubMed Google Scholar
• Stassen, M., Hultner, L. & Schmitt, E. Classical and alternative pathways of mast cell activation. Crit. Rev. Immunol. 22, 115–140 (2002).
  Article CAS PubMed Google Scholar
• Drummond, P. D. The effect of cutaneous mast cell degranulation on sensitivity to heat. Inflamm. Res. 53, 309–315 (2004).
  Article CAS PubMed Google Scholar
• Parada, C. A., Tambeli, C. H., Cunha, F. Q. & Ferreira, S. H. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 102, 937–944 (2001).
  Article CAS PubMed Google Scholar
• Ribeiro, R. A. et al. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur. J. Pharmacol. 387, 111–118 (2000).
  Article CAS PubMed Google Scholar
• Hoogerwerf, W. A. et al. The role of mast cells in the pathogenesis of pain in chronic pancreatitis. BMC Gastroenterol. 5, 8 (2005).
  Article PubMed PubMed Central Google Scholar
• Piovezan, A. P. et al. Endothelins contribute towards nociception induced by antigen in ovalbumin-sensitised mice. Br. J. Pharmacol. 141, 755–763 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Oberpenning, F., van Ophoven, A. & Hertle, L. Interstitial cystitis: an update. Curr. Opin. Urol. 12, 321–332 (2002).
  Article PubMed Google Scholar
• Thomazzi, S. M., Ribeiro, R. A., Campos D. I., Cunha, F. Q. & Ferreira, S. H. Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of supernatant of LPS-stimulated macrophages. Mediators Inflamm. 6, 195–200 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Souza, G. E., Cunha, F. Q., Mello, R. & Ferreira, S. H. Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion. Agents Actions 24, 377–380 (1988).
  Article CAS PubMed Google Scholar
• Brack, A. & Stein, C. Potential links between leukocytes and antinociception. Pain 111, 1–2 (2004).
  Article PubMed Google Scholar
• Heuft, H. G., Goudeva, L. & Blasczyk, R. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors. Ann. Hematol. 83, 279–285 (2004).
  Article CAS PubMed Google Scholar
• Chou, T. C., Chang, L. P., Li, C. Y., Wong, C. S. & Yang, S. P. The antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth. Analg. 97, 1724–1729 (2003).
  Article CAS PubMed Google Scholar
• McMahon, S. B., Cafferty, W. B. & Marchand, F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444–462 (2005). This article reviews immune and glial components of experimental pain, highlighting the actions of some of the key immune-derived mediators and modulators of pain transmission.
  Article CAS PubMed Google Scholar
• Bennett, G., al Rashed, S., Hoult, J. R. & Brain, S. D. Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 77, 315–322 (1998).
  Article CAS PubMed Google Scholar
• Farquhar-Smith, W. P. & Rice, A. S. A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesia. Anesthesiology 99, 1391–1401 (2003).
  Article PubMed Google Scholar
• Sibilia, J. Novel concepts and treatments for autoimmune disease: ten focal points. Joint Bone Spine 71, 511–517 (2004).
  Article PubMed Google Scholar
• McMahon, S. B., Bennett, D. L. H. & Bevan S. in Textbook of Pain (eds McMahon, S. B. & Koltzenburg, M.) Chapter 3 (Elsevier, London, in the press).
• Omote, K. et al. Peripheral nitric oxide in carrageenan-induced inflammation. Brain Res. 912, 171–175 (2001).
  Article CAS PubMed Google Scholar
• Thomsen, L. L. & Olesen, J. Nitric oxide in primary headaches. Curr. Opin. Neurol. 14, 315–321 (2001).
  Article CAS PubMed Google Scholar
• Aley, K. O., McCarter, G. & Levine, J. D. Nitric oxide signaling in pain and nociceptor sensitization in the rat. J. Neurosci. 18, 7008–7014 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hanauer, S. B. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies. Rev. Gastroenterol. Disord. 4 (Suppl. 3), S18–S24 (2004).
  PubMed Google Scholar
• Roberts, L. & McColl, G. J. Tumour necrosis factor inhibitors: risks and benefits in patients with rheumatoid arthritis. Intern. Med. J. 34, 687–693 (2004).
  Article CAS PubMed Google Scholar
• Bonnington, J. K. & McNaughton, P. A. Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J. Physiol. (Lond.) 551, 433–446 (2003).
  Article CAS Google Scholar
• Hwang, S. W. et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl Acad. Sci. USA 97, 6155–6160 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Noorbakhsh, F., Vergnolle, N., Hollenberg, M. D. & Power, C. Proteinase-activated receptors in the nervous system. Nature Rev. Neurosci. 4, 981–990 (2003).
  Article CAS Google Scholar
• Oh, S. B. et al. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 21, 5027–5035 (2001). The first evidence that chemokines have a direct effect on primary nociceptive neurons, and, therefore, a potential role in pain transmission.
  Article CAS PubMed PubMed Central Google Scholar
• Sindrup, S. H. & Jensen, T. S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83, 389–400 (1999).
  Article CAS PubMed Google Scholar
• Le Bars, D., Gozariu, M. & Cadden, S. W. Animal models of nociception. Pharmacol. Rev. 53, 597–652 (2001).
  CAS PubMed Google Scholar
• Ossipov, M. H., Lai, J., Malan, T. P. Jr & Porreca, F. Spinal and supraspinal mechanisms of neuropathic pain. Ann. NY Acad. Sci. 909, 12–24 (2000).
  Article CAS PubMed Google Scholar
• Zuo, Y., Perkins, N. M., Tracey, D. J. & Geczy, C. L. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105, 467–479 (2003).
  Article PubMed Google Scholar
• Perkins, N. M. & Tracey, D. J. Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience 101, 745–757 (2000).
  Article CAS PubMed Google Scholar
• Daemen, M. A. et al. Neurogenic inflammation in an animal model of neuropathic pain. Neurol. Res. 20, 41–45 (1998).
  Article CAS PubMed Google Scholar
• Levine, J. D., Coderre, T. J., White, D. M., Finkbeiner, W. E. & Basbaum, A. I. Denervation-induced inflammation in the rat. Neurosci. Lett. 119, 37–40 (1990).
  Article CAS PubMed Google Scholar
• Cui, J. G., Holmin, S., Mathiesen, T., Meyerson, B. A. & Linderoth, B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88, 239–248 (2000).
  Article CAS PubMed Google Scholar
• Sommer, C. & Schafers, M. Painful mononeuropathy in C57BL/Wld mice with delayed Wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784, 154–162 (1998).
  Article CAS PubMed Google Scholar
• Myers, R. R., Heckman, H. M. & Rodriguez, M. Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration, and regeneration in normal mice. Exp. Neurol. 141, 94–101 (1996).
  Article CAS PubMed Google Scholar
• Liu, T., van Rooijen, N. & Tracey, D. J. Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury. Pain 86, 25–32 (2000).
  Article CAS PubMed Google Scholar
• Heumann, R. et al. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc. Natl Acad. Sci. USA 84, 8735–8739 (1987).
  Article CAS PubMed PubMed Central Google Scholar
• Rutkowski, M. D., Pahl, J. L., Sweitzer, S., van Rooijen, N. & DeLeo, J. A. Limited role of macrophages in generation of nerve injury-induced mechanical allodynia. Physiol. Behav. 71, 225–235 (2002).
  Article Google Scholar
• Moalem, G., Xu, K. & Yu, L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 129, 767–777 (2004).
  Article CAS PubMed Google Scholar
• Tsai, Y. C., Won, S. J. & Lin, M. T. Effects of morphine on immune response in rats with sciatic constriction injury. Pain 88, 155–160 (2000).
  Article CAS PubMed Google Scholar
• Tsai, Y. C. & Won, S. J. Effects of tramadol on T lymphocyte proliferation and natural killer cell activity in rats with sciatic constriction injury. Pain 92, 63–69 (2001).
  Article CAS PubMed Google Scholar
• Lu, X. & Richardson, P. M. Responses of macrophages in rat dorsal root ganglia following peripheral nerve injury. J. Neurocytol. 22, 334–341 (1993).
  Article CAS PubMed Google Scholar
• Sommer, C. & Schroder, J. M. HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts. Acta Neuropathol. (Berl.) 89, 63–71 (1995). One of the first papers to identify a role for macrophages in pain after peripheral nerve injury.
  Article CAS Google Scholar
• Hu, P. & McLachlan, E. M. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112, 23–38 (2002).
  Article CAS PubMed Google Scholar
• Dina, O. A. et al. Integrin signaling in inflammatory and neuropathic pain in the rat. Eur. J. Neurosci. 19, 634–642 (2004).
  Article PubMed Google Scholar
• Fu, W. M. et al. Inhibition of neuropathic pain by a potent disintegrin — triflavin. Neurosci. Lett. 368, 263–268 (2004).
  Article CAS PubMed Google Scholar
• Sweitzer, S. M., White, K. A., Dutta, C. & DeLeo, J. A. The differential role of spinal MHC class II and cellular adhesion molecules in peripheral inflammatory versus neuropathic pain in rodents. J. Neuroimmunol. 125, 82–93 (2002).
  Article CAS PubMed Google Scholar
• Boddeke, E. W. Involvement of chemokines in pain. Eur. J. Pharmacol. 429, 115–119 (2001). An informative review about the role of chemokines in pain.
  Article CAS PubMed Google Scholar
• George, A., Schmidt, C., Weishaupt, A., Toyka, K. V. & Sommer, C. Serial determination of tumor necrosis factor-α content in rat sciatic nerve after chronic constriction injury. Exp. Neurol. 160, 124–132 (1999).
  Article CAS PubMed Google Scholar
• Schafers, M., Svensson, C. I., Sommer, C. & Sorkin, L. S. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 23, 2517–2521 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Schafers, M., Geis, C., Svensson, C. I., Luo, Z. D. & Sommer, C. Selective increase of tumour necrosis factor-α in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur. J. Neurosci. 17, 791–804 (2003).
  Article PubMed Google Scholar
• Wagner, R. & Myers, R. R. Schwann cells produce tumor necrosis factor α: expression in injured and non-injured nerves. Neuroscience 73, 625–629 (1996).
  Article CAS PubMed Google Scholar
• Wagner, R. & Myers, R. R. Endoneurial injection of TNF-α produces neuropathic pain behaviors. Neuroreport 7, 2897–2901 (1996). A historically important article that provided some of the first evidence that TNFα might be involved in pain modulation after peripheral nerve injury.
  Article CAS PubMed Google Scholar
• Sommer, C. et al. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res. 913, 86–89 (2001).
  Article CAS PubMed Google Scholar
• Sommer, C., Schafers, M., Marziniak, M. & Toyka, K. V. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 6, 67–72 (2001).
  Article CAS PubMed Google Scholar
• Lindenlaub, T., Teuteberg, P., Hartung, T. & Sommer, C. Effects of neutralizing antibodies to TNF-α on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res. 866, 15–22 (2000).
  Article CAS PubMed Google Scholar
• Schafers, M., Brinkhoff, J., Neukirchen, S., Marziniak, M. & Sommer, C. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-α and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci. Lett. 310, 113–116 (2001).
  Article CAS PubMed Google Scholar
• Sommer, C., Schmidt, C. & George, A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp. Neurol. 151, 138–142 (1998).
  Article CAS PubMed Google Scholar
• George, A., Buehl, A. & Sommer, C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp. Neurol. 192, 163–166 (2005).
  Article CAS PubMed Google Scholar
• Sommer, C., Petrausch, S., Lindenlaub, T. & Toyka, K. V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 270, 25–28 (1999).
  Article CAS PubMed Google Scholar
• Fukuoka, H., Kawatani, M., Hisamitsu, T. & Takeshige, C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 β in the rat. Brain Res. 657, 133–140 (1994).
  Article CAS PubMed Google Scholar
• Obreja, O., Rathee, P. K., Lips, K. S., Distler, C. & Kress, M. IL-1 β potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J. 16, 1497–1503 (2002).
  Article CAS PubMed Google Scholar
• De Jongh, R. F. et al. The role of interleukin-6 in nociception and pain. Anesth. Analg. 96, 1096–1103 (2003). This article reviews the involvement of IL-6 in pain.
  Article CAS PubMed Google Scholar
• Murphy, P. G. et al. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur. J. Neurosci. 11, 2243–2253 (1999).
  Article CAS PubMed Google Scholar
• Ramer, M. S., Murphy, P. G., Richardson, P. M. & Bisby, M. A. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 78, 115–121 (1998).
  Article CAS PubMed Google Scholar
• Tanaka, T., Minami, M., Nakagawa, T. & Satoh, M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci. Res. 48, 463–469 (2004).
  Article CAS PubMed Google Scholar
• Abbadie, C. et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl Acad. Sci. USA 100, 7947–7952 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Milligan, E. D. et al. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. 20, 2294–2302 (2004).
  Article CAS PubMed Google Scholar
• Verge, G. M. et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20, 1150–1160 (2004). The first paper to show that fractalkine release by neurons could be an activator of microglia.
  Article PubMed Google Scholar
• Cunha, J. M., Cunha, F. Q., Poole, S. & Ferreira, S. H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br. J. Pharmacol. 130, 1418–1424 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Sommer, C. & Kress, M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci. Lett. 361, 184–187 (2004). A short review on the involvement of different cytokines in inflammatory and neuropathic pain.
  Article CAS PubMed Google Scholar
• Ma, W. & Eisenach, J. C. Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation. Exp. Neurol. 183, 581–592 (2003).
  Article CAS PubMed Google Scholar
• Ma, W. & Eisenach, J. C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. 15, 1037–1047 (2002).
  Article PubMed Google Scholar
• Ma, W. & Eisenach, J. C. Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, calcitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience 121, 681–690 (2003).
  Article CAS PubMed Google Scholar
• Sweitzer, S. M., Hickey, W. F., Rutkowski, M. D., Pahl, J. L. & DeLeo, J. A. Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain 100, 163–170 (2002).
  Article PubMed Google Scholar
• Rutkowski, M. D., Lambert, F., Raghavendra, V. & DeLeo, J. A. Presence of spinal B7.2 (CD86) but not B7.1 (CD80) co-stimulatory molecules following peripheral nerve injury: role of nondestructive immunity in neuropathic pain. J. Neuroimmunol. 146, 94–98 (2004).
  Article CAS PubMed Google Scholar
• De Nicola, A. F. et al. Steroid effects on glial cells: detrimental or protective for spinal cord function? Ann. NY Acad. Sci. 1007, 317–328 (2003).
  Article CAS PubMed Google Scholar
• Meller, S. T., Dykstra, C., Grzybycki, D., Murphy, S. & Gebhart, G. F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33, 1471–1478 (1994).
  Article CAS PubMed Google Scholar
• Milligan, E. D. et al. Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res. 861, 105–116 (2000).
  Article CAS PubMed Google Scholar
• Milligan, E. D. et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 23, 1026–1040 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Aumeerally, N., Allen, G. & Sawynok, J. Glutamate-evoked release of adenosine and regulation of peripheral nociception. Neuroscience 127, 1–11 (2004).
  Article CAS PubMed Google Scholar
• Raghavendra, V., Tanga, F. & DeLeo, J. A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 306, 624–630 (2003). This paper provides the first evidence that microglia are involved in the initiation, rather than the maintenance, of neuropathic pain.
  Article CAS PubMed Google Scholar
• Ledeboer, A. et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115, 71–83 (2005).
  Article CAS PubMed Google Scholar
• Hassel, B., Paulsen, R. E., Johnsen, A. & Fonnum, F. Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res. 576, 120–124 (1992).
  Article CAS PubMed Google Scholar
• Zhang, S. C., Goetz, B. D. & Duncan, I. D. Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia 41, 191–198 (2003).
  Article PubMed Google Scholar
• Tsuda, M. et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778–783 (2003). An important study showing that P2X4 is a key mediator of microglial activation and is involved in neuropathic, but not inflammatory, pain.
  Article CAS PubMed Google Scholar
• Guillemin, G. J. & Brew, B. J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388–397 (2004).
  Article CAS PubMed Google Scholar
• Colburn, R. W., Rickman, A. J. & DeLeo, J. A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp. Neurol. 157, 289–304 (1999).
  Article CAS PubMed Google Scholar
• Colburn, R. W. et al. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J. Neuroimmunol. 79, 163–175 (1997).
  Article CAS PubMed Google Scholar
• Hashizume, H., DeLeo, J. A., Colburn, R. W. & Weinstein, J. N. Spinal glial activation and cytokine expression after lumbar root injury in the rat. Spine 25, 1206–1217 (2000).
  Article CAS PubMed Google Scholar
• Winkelstein, B. A. & DeLeo, J. A. Nerve root injury severity differentially modulates spinal glial activation in a rat lumbar radiculopathy model: considerations for persistent pain. Brain Res. 956, 294–301 (2002).
  Article CAS PubMed Google Scholar
• Raghavendra, V., Tanga, F., Rutkowski, M. D. & DeLeo, J. A. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 104, 655–664 (2003).
  Article CAS PubMed Google Scholar
• Tanga, F. Y., Raghavendra, V. & DeLeo, J. A. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem. Int. 45, 397–407 (2004).
  Article CAS PubMed Google Scholar
• Coyle, D. E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 23, 75–83 (1998).
  Article CAS PubMed Google Scholar
• Zhuang, Z. Y., Gerner, P., Woolf, C. J. & Ji, R. R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114, 149–159 (2005).
  Article PubMed Google Scholar
• Le Feuvre, R., Brough, D. & Rothwell, N. Extracellular ATP and P2X7 receptors in neurodegeneration. Eur. J. Pharmacol. 447, 261–269 (2002).
  Article CAS PubMed Google Scholar
• Chessell, I. P. et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386–396 (2005).
  Article CAS PubMed Google Scholar
• Klein, M. A. et al. Impaired neuroglial activation in interleukin-6 deficient mice. Glia 19, 227–233 (1997).
  Article CAS PubMed Google Scholar
• Winkelstein, B. A., Rutkowski, M. D., Sweitzer, S. M., Pahl, J. L. & DeLeo, J. A. Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment. J. Comp. Neurol. 439, 127–139 (2001).
  Article CAS PubMed Google Scholar
• Tanga, F. Y., Nutile-McMenemy, N. & DeLeo, J. A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl Acad. Sci. USA 102, 5856–5861 (2005). Showed, for the first time, the involvement of TLR4 in microglial activation in neuropathic pain models.
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. Y. et al. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport 13, 2483–2486 (2002).
  Article CAS PubMed Google Scholar
• Jin, S. X., Zhuang, Z. Y., Woolf, C. J. & Ji, R. R. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J. Neurosci. 23, 4017–4022 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S. & Inoue, K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45, 89–95 (2004).
  Article PubMed Google Scholar
• Tsuda, M., Inoue, K. & Salter, M. W. Neuropathic pain and spinal microglia: a big problem from molecules in 'small' glia. Trends Neurosci. 28, 101–107 (2005). A critical review about the influence of microglia in neuropathic pain.
  Article CAS PubMed Google Scholar
• Watkins, L. R. & Maier, S. F. Glia: a novel drug discovery target for clinical pain. Nature Rev. Drug Discov. 2, 973–985 (2003).
  Article CAS Google Scholar
• Sung, C. S. et al. Intrathecal interleukin-1β administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res. 1015, 145–153 (2004).
  Article CAS PubMed Google Scholar
• Reeve, A. J., Patel, S., Fox, A., Walker, K. & Urban, L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain 4, 247–257 (2000).
  Article CAS PubMed Google Scholar
• DeLeo, J. A., Colburn, R. W., Nichols, M. & Malhotra, A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16, 695–700 (1996).
  Article CAS PubMed Google Scholar
• DeLeo, J. A., Colburn, R. W. & Rickman, A. J. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res. 759, 50–57 (1997).
  Article CAS PubMed Google Scholar
• Holguin, A. et al. HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 110, 517–530 (2004).
  Article CAS PubMed Google Scholar
• Wu, J., Fang, L., Lin, Q. & Willis, W. D. Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain 94, 47–58 (2001).
  Article CAS PubMed Google Scholar
• Durrenberger, P. F. et al. Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury. J. Peripher. Nerv. Syst. 9, 15–25 (2004).
  Article CAS PubMed Google Scholar
• Broom, D. C. et al. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 124, 891–900 (2004).
  Article CAS PubMed Google Scholar
• Schafers, M., Marziniak, M., Sorkin, L. S., Yaksh, T. L. & Sommer, C. Cyclooxygenase inhibition in nerve-injury- and TNF-induced hyperalgesia in the rat. Exp. Neurol. 185, 160–168 (2004).
  Article CAS PubMed Google Scholar
• Zhu, X. & Eisenach, J. C. Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology 99, 1175–1179 (2003).
  Article CAS PubMed Google Scholar
• Ma, W., Du, W. & Eisenach, J. C. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 937, 94–99 (2002).
  Article CAS PubMed Google Scholar
• Finnerup, N. B. & Jensen, T. S. Spinal cord injury pain — mechanisms and treatment. Eur. J. Neurol. 11, 73–82 (2004). A good review about spinal cord injury and pain, with a useful section on different underlying mechanisms.
  Article CAS PubMed Google Scholar
• Popovich, P. G. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog. Brain Res. 128, 43–58 (2000).
  Article CAS PubMed Google Scholar
• Watanabe, T. et al. Differential activation of microglia after experimental spinal cord injury. J. Neurotrauma 16, 255–265 (1999).
  Article CAS PubMed Google Scholar
• Marchand, F., Grist, J., Bradbury, E. J. & McMahon, S. B. Role of microglia in spinal cord injury pain in rats. Intl Assoc. Study Pain Abstr. 136265 (2005).
• Gris, D. et al. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function. J. Neurosci. 24, 4043–4051 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Oatway, M. A., Chen, Y., Bruce, J. C., Dekaban, G. A. & Weaver, L. C. Anti-CD11d integrin antibody treatment restores normal serotonergic projections to the dorsal, intermediate, and ventral horns of the injured spinal cord. J. Neurosci. 25, 637–647 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Demjen, D. et al. Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nature Med. 10, 389–395 (2004).
  Article CAS PubMed Google Scholar
• Pearse, D. D., Pereira, F. C., Stolyarova, A., Barakat, D. J. & Bunge, M. B. Inhibition of tumour necrosis factor-α by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages. Eur. J. Neurosci. 20, 3387–3396 (2004).
  Article PubMed Google Scholar
• Perrin, F. E., Lacroix, S., Aviles-Trigueros, M. & David, S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration. Brain 128, 854–866 (2005).
  Article PubMed Google Scholar
• Wang, X. et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nature Med. 10, 821–827 (2004).
  Article CAS PubMed Google Scholar
• Hu, X. et al. Activation of nuclear factor-κB signaling pathway by interleukin-1 after hypoxia/ischemia in neonatal rat hippocampus and cortex. J. Neurochem. 93, 26–37 (2005).
  Article CAS PubMed Google Scholar
• Qiu, J. et al. Bcl-xL expression after contusion to the rat spinal cord. J. Neurotrauma 18, 1267–1278 (2001).
  Article CAS PubMed Google Scholar
• Plunkett, J. A., Yu, C. G., Easton, J. M., Bethea, J. R. & Yezierski, R. P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp. Neurol. 168, 144–154 (2001).
  Article CAS PubMed Google Scholar
• Abraham, K. E., McMillen, D. & Brewer, K. L. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 124, 945–952 (2004).
  Article CAS PubMed Google Scholar
• Bethea, J. R. et al. Systemically administered interleukin-10 reduces tumor necrosis factor-α production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 16, 851–863 (1999).
  Article CAS PubMed Google Scholar
• Aicher, S. A., Silverman, M. B., Winkler, C. W. & Bebo, B. F. Jr. Hyperalgesia in an animal model of multiple sclerosis. Pain 110, 560–570 (2004).
  Article CAS PubMed Google Scholar
• Gilden, D. H. Infectious causes of multiple sclerosis. Lancet Neurol. 4, 195–202 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Vartanian, T. K., Zamvil, S. S., Fox, E. & Sorensen, P. S. Neutralizing antibodies to disease-modifying agents in the treatment of multiple sclerosis. Neurology 63, S42–S49 (2004).
  Article CAS PubMed Google Scholar
• Mahad, D. J., Howell, S. J. & Woodroofe, M. N. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 72, 498–502 (2002).
  CAS PubMed PubMed Central Google Scholar
• Toms, R., Weiner, H. L. & Johnson, D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30, 169–177 (1990).
  Article CAS PubMed Google Scholar
• Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71–82 (2003).
  Article CAS PubMed Google Scholar
• Panes, J., Perry, M. & Granger, D. N. Leukocyte–endothelial cell adhesion: avenues for therapeutic intervention. Br. J. Pharmacol. 126, 537–550 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Murphy, P. M. et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145–176 (2000).
  CAS PubMed Google Scholar
• Gilroy, D. W., Lawrence, T., Perretti, M. & Rossi, A. G. Inflammatory resolution: new opportunities for drug discovery. Nature Rev. Drug Discov. 3, 401–416 (2004). A review that illustrates the concept of anti-inflammation and the endogenous control of the inflammatory response.
  Article CAS Google Scholar
• Hannon, R. et al. Aberrant inflammatory responses and resistance to glucocorticoids in the annexin 1−/− mouse. FASEB J. 17, 253–255 (2003). This study reports the initial description of the annexin 1 null mouse, and the impact on the host inflammatory response of removing this endogenous inhibitory mediator.
  Article CAS PubMed Google Scholar
• Malcangio, M. et al. A novel control mechanism based on GDNF modulation of somatostatin release from sensory neurones. FASEB J. 16, 730–732 (2002).
  Article CAS PubMed Google Scholar
• Arita, M. et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713–722 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Ferreira, S. H. et al. Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br. J. Pharmacol. 121, 883–888 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Pieretti, S., Di Giannuario, A., De Felice, M., Perretti, M. & Cirino, G. Stimulus-dependent specificity for annexin 1 inhibition of the inflammatory nociceptive response: the involvement of the receptor for formylated peptides. Pain 109, 52–63 (2004). An important study that describes the effects of annexin 1 bioactive peptidomimetics in models of peripheral inflammatory pain.
  Article CAS PubMed Google Scholar
• Melzer, P., Savchenko, V. & McKanna, J. A. Microglia, astrocytes, and macrophages react differentially to central and peripheral lesions in the developing and mature rat whisker-to-barrel pathway: a study using immunohistochemistry for lipocortin1, phosphotyrosine, s100β, and mannose receptors. Exp. Neurol. 168, 63–77 (2001).
  Article CAS PubMed Google Scholar
• Le, Y. et al. Amyloid β42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123 (2001). A comprehensive analysis of FPRL1 expression and function on microglia, with strong implications for Alzheimer's disease.
  Article CAS PubMed PubMed Central Google Scholar
• Harada, M. et al. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem. Biophys. Res. Commun. 324, 255–261 (2004).
  Article CAS PubMed Google Scholar
• Minghetti, L. et al. Down-regulation of microglial cyclo-oxygenase-2 and inducible nitric oxide synthase expression by lipocortin 1. Br. J. Pharmacol. 126, 1307–1314 (1999).
  Article CAS PubMed PubMed Central Google Scholar